|1.||Coselli, Joseph S: 4 articles (03/2012 - 05/2002)|
|2.||Kumar, Arun: 3 articles (08/2004 - 01/2003)|
|3.||Kaye, Andrew H: 3 articles (08/2004 - 01/2003)|
|4.||LeMaire, Scott A: 2 articles (03/2012 - 05/2002)|
|5.||Mues, Adam C: 2 articles (01/2012 - 08/2011)|
|6.||Graversen, Joseph A: 2 articles (01/2012 - 08/2011)|
|7.||Landman, Jaime: 2 articles (01/2012 - 08/2011)|
|8.||Cisneros, Nieves: 2 articles (08/2010 - 02/2007)|
|9.||Maldonado, Victor Hugo: 2 articles (08/2010 - 02/2007)|
|10.||de la Portilla, Fernando: 2 articles (08/2010 - 02/2007)|
11/01/2003 - "This prospective study evaluates the efficacy of a new bioadhesive--BioGlue, as a dural sealant in preventing CSF fistula. "
01/01/2003 - "This study evaluates the use of a new bioadhesive, Bioglue as an adjunct in reconstructing the sellar floor and preventing CSF fistula and investigates the possible complications associated with its use. "
01/01/2012 - "The patient was treated with Bioglue(®) and had complete resolution of the fistula at follow-up. "
08/01/2010 - "Long-term results change conclusions on BioGlue in the treatment of high transsphincteric anal fistulas."
11/01/2009 - "Successful endobronchial seal of surgical bronchopleural fistulas using BioGlue."
06/01/2003 - "The rats in the control group had a mean seroma volume of 5.19 ml (standard deviation, +/- 3.65 ml; N = 11), whereas the rats treated with BioGlue had a mean seroma volume of 0.25 +/- 0.43 ml (N = 11). "
07/01/2007 - "Fat, muscle, and a 1-mm epidural layer of BioGlue were used to seal the dural sutures and to obliterate any potential seroma-forming dead space. "
07/01/2007 - "We reviewed our experience with BioGlue Surgical Adhesive, a protein-based adhesive, as an adjunct in free tissue transfer procedures to prevent CSF leakage and seroma formation. "
06/01/2003 - "This study demonstrates that BioGlue can be used as a tissue adhesive that reduces seroma formation significantly in the rat mastectomy model (p = 0.0008). "
06/01/2003 - "In this study the authors investigated the efficacy of a synthetic glutaraldehyde-based tissue adhesive (BioGlue; Cryolife, Inc., Kennesaw, GA) in seroma prevention in the rat mastectomy seroma model. "
|3.||Wounds and Injuries (Trauma)
01/01/2012 - "BioGlue sealant was found to be effective in sealing the tracheal wound in all but 1 of the canines. "
03/01/2012 - "To our knowledge, this is the first description of the use of BioGlue for repair of penetrating cardiac injuries. "
03/01/2012 - "BioGlue hemostasis of penetrating cardiac wounds in proximity to the left anterior descending coronary artery."
01/01/2012 - "The tracheal wound was closed using BioGlue sealant. "
01/01/2012 - "In this report, we describe a simple wound closure method using BioGlue sealant. "
09/01/2008 - "We sought to develop and examine the feasibility and efficacy of a streamlined sutureless system of repairing parenchymal and collecting system defects using BioGlue (bovine albumin-glutaraldehyde adhesive) and ProPatch (bovine pericardial patch) in swine under physiological conditions and mechanical stress imposed by chronic ureteral obstruction caused by complete ureteral transaction. "
|2.||Tissue Adhesives (Tissue Adhesive)
|3.||Fibrin Tissue Adhesive (Fibrin Sealant)
|6.||Bovine Serum Albumin
|8.||glucuronyl glucosamine glycan sulfate (Vessel)
|10.||Staphylococcal Protein A (A, Protein)
|5.||Deep Hypothermia Induced Circulatory Arrest